Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 105967
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105967
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105967
Table 1 Correlations between charged multivesicular body protein 7 expression and patient clinical characters
Characteristic | n | Expression of CHMP7 | P value |
Age, years | 0.709 | ||
≤ 65 | 194 | 3.29 ± 0.54 | |
> 65 | 284 | 3.28 ± 0.49 | |
Gender | 0.126 | ||
Female | 226 | 3.32 ± 0.49 | |
Male | 252 | 3.25 ± 0.52 | |
Pathologic stage | < 0.001 | ||
I and II | 268 | 3.39 ± 0.48 | |
III and IV | 199 | 3.14 ± 0.50 | |
N stage | < 0.001 | ||
N0 | 284 | 3.37 ± 0.50 | |
N1 and N2 | 194 | 3.16 ± 0.49 | |
M stage | < 0.001 | ||
M0 | 349 | 3.30 ± 0.49 | |
M1 | 66 | 3.03 ± 0.49 | |
Lymphatic invasion | 0.005 | ||
No | 266 | 3.35 ± 0.50 | |
Yes | 168 | 3.21 ± 0.48 |
- Citation: Wei JR, Ouyang YN, Tang MT, Yuan JZ, Wang PL, Jiang LH, Wu LC. Charged multivesicular body protein 7 was identified as a prognostic biomarker correlated with metastasis in colorectal cancer. World J Gastrointest Oncol 2025; 17(6): 105967
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/105967.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.105967